See also this year's filing and all EDGAR filings for this company.
PDF Report 0001369786_2013_Sagent_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001369786, Sagent Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 147,268,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 4,277,000 |
| 2 | PropertyPlantAndEquipmentNet | 780,000 |
| 3 | remainder_Assets | 19,990,000 |
| 4 | LiabilitiesCurrent | 40,454,000 |
| 5 | LiabilitiesNoncurrent | 6,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 30,093,000 |
| 9 | ResearchAndDevelopmentExpense | 17,136,000 |
| 10 | remainder_Expenses | 153,446,000 |
| 11 | remainder_Revenues | 183,615,000 |
| 12 | remainder_NetIncome | 243,000 |
| 13 | remainder_ComprehensiveNetIncome | 338,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 172,315,000 |
| 1 | Liabilities | 40,460,000 |
| 2 | Expenses | 200,675,000 |
| 3 | Revenues | 183,615,000 |
| 4 | StockholdersEquity | 131,855,000 |
| 5 | NetIncome | -16,817,000 |
| 6 | ComprehensiveNetIncome | -16,648,000 |
| 7 | BaseVar | 298,823,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.55 |
| 9 | EconomicCapitalRatio | 3.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
